Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$8.19 - $13.89 $92,899 - $157,554
-11,343 Reduced 21.81%
40,661 $352,000
Q4 2021

Feb 07, 2022

BUY
$12.98 - $29.75 $64,900 - $148,750
5,000 Added 10.64%
52,004 $743,000
Q3 2021

Nov 08, 2021

BUY
$12.13 - $23.82 $387,468 - $760,882
31,943 Added 212.09%
47,004 $1.03 Million
Q4 2017

Mar 15, 2018

BUY
$7.95 - $11.15 $119,734 - $167,930
15,061
15,061 $136 Million

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $90.9M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.